10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

☒	Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended September 30, 2023
☐	Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from __________ to __________
Commission File Number:  000-55704

Right On Brands, Inc.

(Exact name of registrant as specified in its charter)

Nevada	45-1994478
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

6501 Dalrock Road, Suite 100, Rowlett, TX 75089

(Address of principal executive offices) 

(214) 299-9528 

(Registrant’s telephone number) 

N/A 

(Former name, former address and former fiscal year, if changed since last report)  

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
None	N/A	N/A

Indicated by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days ☒ Yes   ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit). ☒ Yes   ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

☐	Large accelerated filer	☐	Accelerated filer
☒	Non-accelerated filer	☒	Smaller reporting company
		☐	Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes   ☒ No

As of November 14, 2023, there were 25,498,064 shares of common stock, par value $0.001 per share, outstanding.

TABLE OF CONTENTS

		Page
PART I - FINANCIAL INFORMATION
Item 1:	Financial Statements	3
Item 2:	Management’s Discussion and Analysis of Financial Condition and Results of Operations	4
Item 3:	Quantitative and Qualitative Disclosures About Market Risk	8
Item 4:	Controls and Procedures	8
PART II - OTHER INFORMATION
Item 1:	Legal Proceedings	9
Item 1A:	Risk Factors	9
Item 2:	Unregistered Sales of Equity Securities and Use of Proceeds	9
Item 3:	Defaults Upon Senior Securities	9
Item 4:	Mine Safety Disclosures	9
Item 5:	Other Information	9
Item 6:	Exhibits	10

2

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

Our financial statements included in this Form 10-Q are as follows:

Condensed Consolidated Balance Sheets as of September 30, 2023 and March 31, 2023 (unaudited);	F-1
Condensed Consolidated Statements of Operations for the three and six months ended September 30, 2023 and 2022 (unaudited);	F-2
Condensed Consolidated Statements of Stockholders’ Deficit for the six months ended September 30, 2023 and 2022 (unaudited);	F-3
Condensed Consolidated Statements of Cash Flows for the six months ended September 30, 2023 and 2022 (unaudited);	F-4
Notes to Condensed Consolidated Financial Statements (unaudited).	F-5

These condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and the SEC instructions to Form 10-Q. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the interim period ended September 30, 2023, are not necessarily indicative of the results that can be expected for the full year.

3

RIGHT ON BRANDS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

	September 30,			March 31,
	2023			2023
Assets
Current assets
Cash	$	20,299		$	33,322
Accounts receivable		24,431			1,798
Inventory		136,445			116,115
Other current assets		3,221			3,221
Total current assets		184,396			154,456
Non-current assets
Property and equipment, net of depreciation		7,085			9,885
Right of use asset		30,673			42,488
Total non-current assets		37,758			52,373
Total assets	$	222,154		$	206,829
Liabilities and Stockholders' Deficit
Current liabilities
Accounts payable	$	87,753		$	77,388
Accrued interest payable		42,388			28,236
Accrued expenses		107,110			104,148
Unearned revenue		12,500			12,500
Lease liability, current portion		23,106			23,388
Notes payable, net of discount		237,890			257,077
Convertible debt, net of discount		210,240			182,051
Derivative liability		134,312			-
Total current liabilities		855,299			684,788
Lease liability, non-current		7,567			19,100
Total liabilities		862,866			703,888
Commitments and contingencies (Note 10)
Stockholders' deficit
Series A Preferred stock; 10,000,000 shares authorized of $0.001 par value; 5,000,000 shares issued		5,000			5,000
Common stock; par value $0.001; 12,000,000,000 shares authorized, 25,498,064 shares issued		25,498			25,498
Additional paid-in capital		15,221,530			15,194,247
Common stock payable		15,000			15,000
Accumulated deficit		(15,932,177	)		(15,761,241	)
Total Right On Brands stockholders' deficit		(665,149	)		(521,496	)
Noncontrolling interest		24,437			24,437
Total stockholders' deficit		(640,712	)		(497,059	)
Total liabilities and stockholders' deficit	$	222,154		$	206,829

The accompanying notes are an integral part of these condensed consolidated financial statements.

F-1

RIGHT ON BRANDS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

	For the three months ended						For the six months ended
	September 30,						September 30,
	2023			2022			2023			2022
Revenues	$	328,914		$	241,111		$	734,759		$	549,465
Cost of goods sold		141,855			138,785			328,030			266,116
Gross profit		187,059			102,326			406,729			283,349
Operating expenses
General and administrative		197,912			144,009			396,097			270,588
Advertising and promotion		9,787			1,164			24,785			7,279
Legal and professional		23,450			35,880			42,482			77,341
Depreciation and amortization		1,400			1,400			2,800			2,800
Total operating expenses		232,549			182,453			466,164			358,008
Loss from operations		(45,490	)		(80,127	)		(59,435	)		(74,659	)
Other income and (expense)
Interest expense		(3,110	)		(3,407	)		(21,442	)		(5,875	)
Amortization of debt discount		(43,161	)		(8,264	)		(49,435	)		(9,754	)
Change in fair value of derivative liability		8			-			161			51,994
Financing costs		-			(4,250	)		(40,785	)		(4,250	)
Gain on settlement of liabilities		-			-			-			140,297
Total other income (expense)		(46,263	)		(15,921	)		(111,501	)		172,412
Net income (loss) including noncontrolling interest	$	(91,753	)	$	(96,048	)	$	(170,936	)	$	97,753
Net income (loss) attributable to noncontrolling interest		-			-			-			-
Net income (loss) attributable to Right on Brands, Inc.	$	(91,753	)	$	(96,048	)	$	(170,936	)	$	97,753
Income (loss) per share - basic	$	(0.00	)	$	(0.00	)	$	(0.01	)	$	0.00
Income (loss) per share - diluted										$	0.00
Weighted average shares outstanding - basic		25,498,064			23,445,178			25,498,064			23,571,743
Weighted average shares outstanding - diluted											23,710,076

The accompanying notes are an integral part of these condensed consolidated financial statements.

F-2

RIGHT ON BRANDS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

(UNAUDITED)

	Preferred Stock				Common Stock						Additional Paid in		Common Stock			Accumulated			Noncontrolling
	Shares		Amount		Shares			Amount			Capital		Payable			Deficit			Interest		Total
Balances, March 31, 2022		5,000,000	$	5,000		23,699,207		$	23,699		$	15,099,083	$	51,820		$	(15,769,967	)	$	24,437	$	(565,928	)
Issuance of common stock issuable		-		-		5,600			6			36,814		(36,820	)		-			-		-
Recession of shares		-		-		(612,456	)		(612	)		612		-			-			-		-
Net income		-		-		-			-			-		-			97,753			-		97,753
Balances, September 30, 2022		5,000,000	$	5,000		23,092,351		$	23,093		$	15,136,509	$	15,000		$	(15,672,214	)		24,437	$	(468,175	)
Balances, March 31, 2023		5,000,000	$	5,000		25,498,064		$	25,498		$	15,194,247	$	15,000		$	(15,761,241	)	$	24,437	$	(497,059	)
Settlement of derivative liability		-		-		-			-			27,283		-			-			-		27,283
Net loss		-		-		-			-			-		-			(170,936	)		-		(170,936	)
Balances, September 30, 2023		5,000,000	$	5,000		25,498,064		$	25,498		$	15,221,530	$	15,000		$	(15,932,177	)	$	24,437	$	(640,712	)

The accompanying notes are an integral part of these condensed consolidated financial statements.

F-3

RIGHT ON BRANDS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	For the six months ended
	September 30,
	2023			2022
OPERATING ACTIVITIES
Net income (loss)	$	(170,936	)	$	97,753
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization		2,800			2,800
Amortization of debt discount		49,435			9,754
Financing costs		40,785			4,250
Change in fair value of derivative liability		(161	)		(51,994	)
Gain on settlement of liabilities		-			(140,297	)
Changes in operating assets and liabilities:
Accounts receivable		(22,633	)		-
Prepaid expenses		-			(6,000	)
Inventory		(20,330	)		(41,297	)
Accounts payable		10,365			17,476
Accrued interest payable		20,957			5,875
Accrued expenses		2,962			(6,197	)
NET CASH USED IN OPERATING ACTIVITIES		(86,756	)		(107,877	)
INVESTING ACTIVITIES
NET CASH USED IN INVESTING ACTIVITIES		-			-
FINANCING ACTIVITIES
Proceeds from notes payable		63,195			202,101
Proceeds from convertible notes payable		65,000			-
Repayment of notes payable		(54,462	)		(109,968	)
NET CASH PROVIDED BY FINANCING ACTIVITIES		73,733			92,133
NET DECREASE IN CASH	$	(13,023	)	$	(15,744	)
CASH, BEGINNING OF PERIOD		33,322			28,056
CASH, END OF PERIOD	$	20,299		$	12,312
CASH PAID FOR INCOME TAXES	$	485		$	-
CASH PAID FOR INTEREST	$	-		$	-
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Discount on note payable	$	14,000		$	-
Discount on note payable from derivative liability	$	70,000		$	-
Discount on convertible note payable from derivative liability	$	50,971		$	-
Settlement of derivative liability	$	27,283		$	-
Accrued interest settled with note payable	$	6,805		$	-
Common stock issued for common stock payable	$	-		$	36,820
Principal and interest settled	$	-		$	33,185
Original issuance discount on notes payable	$	-		$	16,991

The accompanying notes are an integral part of these condensed consolidated financial statements.

F-4

RIGHT ON BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS

Formation and Business Activity

Right on Brands, Inc. (“we” or “the Company” or “Right on Brands”) was incorporated under the laws of the State of Nevada on April 1, 2011, as HealthTalk Live, Inc. On August 10, 2017, the Company amended is articles of incorporation and changed its name to Right On Brands, Inc. On August 31, 2017 the Company's common shares commenced trading under the new stock symbol RTON. The Company’s primary business is the sale of health and wellness products.

The Company has the following wholly owned subsidiaries:

· Endo Brands, Inc.

· Humble Water Company

The Company has the following majority owned subsidiaries:

· Endo & Centre Venture LLC (51% owner)

· Spring Hill Water Company, LLC (49% owner – see Note 7)

The Company, through its subsidiaries Humble Water Company and Endo & Centre Venture LLC, had joint ventures with no activity. The Company has discontinued these joint ventures and Humble Water Company and Endo & Centre Venture LLC contain no assets, liabilities, or operations.

On April 16, 2018, the Company entered into an operating agreement with Centre Manufacturing, Inc. (“Centre”) and agreed to form an LLC. The LLC is owned 51% by the Company and 49% owned by Centre, but all income and losses will be split evenly. The owner of Centre is the former CEO of the Company. On June 19, 2018, the Company formed a majority owned subsidiary, Endo & Centre Venture LLC. No significant activity has occurred to date. At September 30, 2023 and March 31, 2023, the Company owed Centre $14,154, respectively, which is included in accounts payable on the accompanying condensed consolidated balance sheets.

The Company continues to sell health and wellness products focused in the hemp marketplace through online and in-person retail sales.

NOTE 2 – GOING CONCERN

The accompanying condensed consolidated financial statements (the “financial statements" or “consolidated financial statements”) have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. For the period ended September 30, 2023, the Company had an accumulated deficit of approximately $15,932,000, had a net loss of approximately $171,000, and net cash used in operating activities of approximately $87,000, with approximately $735,000 revenue earned, and a lack of profitable operational history. These matters, among others, raise substantial doubt about the Company’s ability to continue as a going concern.

While the Company is attempting to generate greater revenues, the Company’s cash position may not be significant enough to support the Company’s daily operations. Management intends to raise additional funds by way of additional public and/or private offerings of its stock. Management believes that the actions presently being taken to further implement its business plan and generate revenues provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to generate revenues and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate revenues.

The condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

F-5

RIGHT ON BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) and the interim reporting rules of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s latest Annual Report filed with the SEC on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments (unless otherwise indicated), necessary for a fair presentation of the financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year.

Principles of Consolidation

The condensed consolidated financial statements of the Company include the accounts of Right On Brands, Inc. and its wholly owned subsidiaries and majority owned business (Endo Brands, Inc., Humble Water Company, Springhill Water Co, and Endo & Centre Venture LLC). Intercompany accounts and transactions have been eliminated upon consolidation.

Use of Estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash

For purposes of reporting cash flows, the Company has defined cash and cash equivalents as all cash in banks and highly liquid investments available for current use with an initial maturity of three months or less to be cash equivalents. The Company had no cash equivalents at September 30, 2023 or March 31, 2023.

The Company maintains its cash balances at financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”). The FDIC provides coverage of up to $250,000 per depositor, per financial institution, for the aggregate total of depositors’ interest and non-interest-bearing accounts. The Company has not experienced any losses on these accounts and management does not believe that the Company is exposed to any significant risks.

Accounts Receivable

The Company performs periodic credit evaluations of its customers’ financial condition and extends credit to virtually all of its customers on an uncollateralized basis. Credit losses to date have been insignificant and within management’s expectations. The Company provides an allowance for doubtful accounts that is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. Normal accounts receivable are due 30 to 45 days after the issuance of the invoice. Receivables past due more than 60 days are considered delinquent. Delinquent receivables are evaluated for collectability based on individual credit evaluation and specific circumstances of the customer. As of September 30, 2023, and March 31, 2023, the Company’s allowance for doubtful accounts was $0, respectively. The Company did not write off any accounts receivable against the allowance for doubtful accounts during the periods ended September 30, 2023 and 2022, respectively.

Inventory

Inventories are stated at the lower of cost (average cost) or market (net realizable value). Cost includes materials related to the purchase of finished goods to be sold to retail customers. We regularly review inventory quantities on hand, future purchase commitments with our suppliers, and the estimated utility of our inventory. If our review indicates a reduction in utility below carrying value, we reduce our inventory to a new cost basis through a charge to cost of revenue.

F-6

RIGHT ON BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Property and Equipment

Property and equipment are stated at cost. Depreciation is provided by the straight-line method over the useful lives of the related assets, ranging from one to five years.

Recoverability of Long-Lived Assets

The Company's long-lived assets and other assets (consisting of property and equipment) are reviewed for impairment in accordance with the guidance of the FASB ASC 360, "Property, Plant, and Equipment," and FASB ASC 205 "Presentation of Financial Statements". The Company tests for impairment losses on long-lived assets used in operations whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Recoverability of an asset to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. Impairment evaluations involve management's estimates on asset useful lives and future cash flows. Actual useful lives and cash flows could be different from those estimated by management which could have a material effect on our reporting results and financial positions. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals, as considered necessary. Through September 30, 2023, the Company had not experienced impairment losses on its long-lived assets. However, there can be no assurances that demand for the Company's products or services will continue, which could result in an impairment of long-lived assets in the future.

Commitments and Contingencies

Liabilities for loss contingencies arising from claims, assessments, litigation, fines, penalties and other sources are recorded when management assesses that it is probable that a liability has been incurred and the amount can be reasonably estimated.

Share Based Compensation

The Company accounts for equity instruments issued in exchange for the receipt of goods or services from other than employees in accordance with FASB ASC 718, “Compensation – Stock Compensation”. Costs are measured at the estimated fair value of the consideration received or the estimated fair value of the equity instruments issued, whichever is more reliably measurable. The value of equity instruments issued for consideration other than employee services is determined on the earliest of a performance commitment or completion of performance by the provider of goods or services as defined by FASB ASC 718, “Compensation – Stock Compensation”.

Income Taxes

In accordance with FASB ASC 740, "Income Taxes," the Company provides for the recognition of deferred tax assets if realization of such assets is more likely than not. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax basis of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.

In addition, the Company’s management performs an evaluation of all uncertain income tax positions taken or expected to be taken in the course of preparing the Company’s income tax returns to determine whether the income tax positions meet a “more likely than not” standard of being sustained under examination by the applicable taxing authorities. This evaluation is required to be performed for all open tax years, as defined by the various statutes of limitations, for federal and state purposes. If the Company has interest or penalties associated with insufficient taxes paid, such expenses are reported in income tax expense.

F-7

RIGHT ON BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Revenue Recognition

We recognize revenue when our performance obligation is satisfied. Our primary performance obligation (the distribution and sales of hemp products) is satisfied upon the shipment or delivery of products to our customers, which is also when control is transferred. The transfer of control of products to our online customers is typically based on sales terms that do not allow for a right of return after 7 days from the date of purchase. The transfer of control of products to our in-store customers is typically based on sales terms that do not allow for a right of return.

Our products are sold for cash with payments received at pickup or before shipping.

During the six months ended September 30, 2023, our revenues consisted of approximately $149,000 in wholesale revenues and $586,000 in retail revenues.

Fair Value Measurement

ASC Topic 820, “Fair Value Measurement”, requires that certain financial instruments be recognized at their fair values at our balance sheet dates. However, other financial instruments, such as debt obligations, are not required to be recognized at their fair values, but GAAP provides an option to elect fair value accounting for these instruments. GAAP requires the disclosure of the fair values of all financial instruments, regardless of whether they are recognized at their fair values or carrying amounts in our balance sheets. For financial instruments recognized at fair value, GAAP requires the disclosure of their fair values by type of instrument, along with other information, including changes in the fair values of certain financial instruments recognized in income or other comprehensive income. For financial instruments not recognized at fair value, the disclosure of their fair values is provided below under “Financial Instruments.”

Nonfinancial assets, such as property, plant and equipment, and nonfinancial liabilities are recognized at their carrying amounts in the Company’s balance sheets. GAAP does not permit nonfinancial assets and liabilities to be remeasured at their fair values. However, GAAP requires the remeasurement of such assets and liabilities to their fair values upon the occurrence of certain events, such as the impairment of property, plant and equipment. In addition, if such an event occurs, GAAP requires the disclosure of the fair value of the asset or liability along with other information, including the gain or loss recognized in income in the period the remeasurement occurred.

Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities;

Level 2 - Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; or

Level 3 - Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).

The Company did not have any Level 1 or Level 2 assets and liabilities at September 30, 2023 and 2022. The Derivative liabilities are Level 3 fair value measurements.

The following is a summary of activity of Level 3 liabilities during the period ended September 30, 2023:

Balance - March 31, 2023	$	-
Additions		161,756
Settlements		(27,283	)
Change in fair value		(161	)
Balance - September 30, 2023	$	134,312

The following is a summary of activity of Level 3 liabilities during the period ended September 30, 2022:

Balance at March 31, 2022	$	159,106
Settlement		(107,112	)
Change in fair value		(51,994	)
Balance at September 30, 2022	$	-

F-8

RIGHT ON BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Under the Company’s contract ordering policy, the Company first considers common shares issued and outstanding as well as reserved but unissued equity awards, such as under an equity award program. All remaining equity linked instruments such as, but not limited to, options, warrants, and debt and equity with conversion features are evaluated based on the date of issuance. If the number of shares which may be issued under the Company’s agreements exceed the authorized number of shares or are unable to be determined, equity linked instruments from that date forward are considered to be derivative liabilities until such time as the number of shares which may be issued under the Company’s agreements no longer exceed the authorized number of shares and are able to be determined.

On June 22, 2023, the Company issued a note payable agreement which contained default provisions that included a conversion feature meeting the definition of a derivative liability which therefore required bifurcation.

At September 30, 2023, the Company estimated the fair value of the conversion feature derivatives embedded in note payable agreements based on assumptions used in the Cox-Ross-Rubinstein binomial pricing model using the following inputs: the price of the Company’s common stock of $0.014; risk-free interest rates ranging from 5.56% to 5.61%, and expected volatility of the Company’s common stock ranging from 476% to 563%, estimated exercise prices ranging from $0.007575 to $0.025, and terms under one year.

Financial Instruments

The Company’s financial instruments include cash and cash equivalents, receivables, payables, and debt and are accounted for under the provisions of ASC Topic 825, “Financial Instruments”. The carrying amount of these financial instruments, with the exception of discounted debt, as reflected in the consolidated balance sheets approximates fair value.

Convertible Instruments

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815 “Derivatives and Hedging Activities”.

Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. Proceeds from these convertible notes are reported under the financing section of the statements of cash flows. Changes to the fair value of the derivative liability are reported as adjustments to reconcile net loss to net cash used in operating activities in the accompanying statement of cash flows.

Basic and Diluted Loss Per Share

Basic net loss/income per common share is computed using the weighted average number of common shares outstanding. Diluted earnings per share (EPS) include additional dilution from common stock equivalents, such as stock issuable pursuant to the exercise of stock options, warrants and convertible notes. Common stock equivalents are not included in the computation of diluted earnings per share when the Company reports a loss because to do so would be anti-dilutive for periods presented.

Recently Issued Accounting Standards

During the period ended September 30, 2023, and subsequently, there were several new accounting pronouncements issued by the FASB. Each of these pronouncements, as applicable, has been or will be adopted by the Company. Management does not believe the adoption of any of these accounting pronouncements has had or will have a material impact on the Company’s condensed consolidated financial statements.

Subsequent Events

The Company has evaluated all transactions through the date the condensed  consolidated financial statements were issued for subsequent event disclosure consideration.

F-9

RIGHT ON BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 4 – INVENTORY

The Company’s inventory consisted of the following at the respective balance sheet dates:

	September 30, 2023		March 31, 2023
Finished goods	$	136,445	$	116,115
	$	136,445	$	116,115

NOTE 5 – PROPERTY AND EQUIPMENT AND INTANGIBLE ASSETS

The Company’s property and equipment consisted of the following at the respective balance sheet dates:

	September 30, 2023			March 31, 2023
Website development	$	88,965		$	88,965
Automobile		-			31,596
Studio and office equipment		11,910			11,910
Tenant improvements		11,135			11,135
Intangible assets		1,024			1,024
		113,034			144,630
Accumulated depreciation and amortization		(105,949	)		(134,745	)
	$	7,085		$	9,885

Depreciation expense of property and equipment for the periods ended September 30, 2023 and 2022 was $2,800, respectively.

NOTE 6 – DEBT

Notes Payable

On November 22, 2019, the Company issued a $50,000 promissory note to a third-party lender for a $25,000 cash borrowing. Accordingly, a $25,000 discount was recorded at issuance, all of which was amortized by March 31, 2020. The non-interest-bearing note is secured by inventory, matured February 20, 2020, and remains in default at September 30, 2023.

During December 2021, the Company was listed as defendant on a complaint from Noteholder 10 seeking repayment of amounts due under a February 2020 convertible note payable. The Company has recorded all unpaid principal and interest due to Noteholder 10 through March 31, 2022. On April 15, 2022, the Company and Noteholder 10 entered into a settlement agreement whereby the Company will repay Noteholder 10 a total of $115,000 consisting of $25,000 paid on April 18, 2022, $5,000 to be paid monthly from May 15, 2022 to October 15, 2022, $6,250 to be paid monthly from November 15, 2022 to April 15, 2023, and $7,500 to be paid monthly from May 15, 2023 to July 15, 2023. As a result of the settlement, the Company reclassified the note from convertible debt to notes payable. On September 30, 2023, the balance of the note totaled $60,000 and payments are past due.

F-10

RIGHT ON BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

On July 21, 2022, the Company entered into a note payable agreement totaling $89,581, consisting of cash proceeds totaling $72,101, repayment of a prior loan balance totaling $6,999, and loan fees totaling $10,481. The note is to be repaid on an ongoing basis by deducting 19.75% of daily sales and applying against the loan balance. The note matures on January 21, 2024. On September 30, 2023, the balance of the note totaled $51,702.

On August 4, 2022, the Company entered into a note payable agreement for $80,000 received as advances during the three months ended September 30, 2022. The note is to be repaid in $3,000 monthly installments beginning on September 10, 2022, with the remaining balance due at maturity on December 31, 2022. On September 30, 2023, the balance of the note totaled $69,786 and was in default.

On August 11, 2022, the Company entered into a 12% note payable agreement totaling $60,760, consisting of cash proceeds totaling $50,000, financing costs of $4,250, and an original discount totaling $6,510. The note requires monthly payments of $6,805 beginning on September 30, 2022 until maturity on August 11, 2023. The note was repaid during June 2023.

On June 22, 2023, the Company entered into a 12% note payable agreement totaling $84,000, consisting of cash proceeds totaling $63,195, financing costs of $5,000, an original discount totaling $9,000, and accrued interest from the August 11, 2022 note totaling $6,805. The note requires monthly payments of $10,453 beginning on July 30, 2023 until maturity on March 30, 2023. Interest at 12% was accrued at issuance. On September 30, 2023, the balance of the note totaled $63,093.

During the period ended September 30, 2023, the Company incurred $21,442 in interest expenses related to notes payable.

Convertible Debt

At September 30, 2023, the Company's convertible debt related to the notes which can be converted at fixed conversion rates are summarized as follows: 

Noteholder	Origination	Maturity	Interest rate		Fixed conversion rate	Principal balance		Debt discount		Net amount of liabilities presented
Noteholder 8	9/5/2023	12/5/2023		8.00%	$0.025/Share	$	65,000	$	36,811	$	28,189
Noteholder 9	7/7/2016	9/30/2019		6.00%	$25.00/Share		25,000		-		25,000
Noteholder 13	2/16/2021	8/16/2021		6.00%	$3.75/Share		140,000		-		140,000
Noteholder 17	2/17/2023	8/20/2023		6.00%	$0.025/Share		17,051		-		17,051
						$	247,051	$	36,811	$	210,240

At March 31, 2023, the Company's convertible debt related to the notes which can be converted at fixed conversion rates are summarized as follows: 

Noteholder	Origination	Maturity	Interest rate		Fixed conversion rate	Principal balance		Debt discount		Net amount of liabilities presented
Noteholder 9	7/7/2016	9/30/2019		6.00%	$25.00/Share	$	25,000	$	-	$	25,000
Noteholder 13	2/16/2021	8/16/2021		6.00%	$3.75/Share		140,000		-		140,000
Noteholder 17	2/17/2023	8/20/2023		6.00%	$0.025/Share		17,051		-		17,051
						$	182,051	$	-	$	182,051

During the period ended September 30, 2023, the Company incurred interest expenses related to convertible debt totaling $5,833.

The convertible debt held by noteholders 9, 13 and 17 were in default at September 30, 2023.

Noteholder 8 and Noteholder 17 are related parties. Noteholder 8 is the daughter of the Company’s CEO and Noteholder 17 is an entity controlled by family members of the Company’s CEO.

F-11

RIGHT ON BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Future Maturities

The Company’s future maturities of notes payable and convertible debt are as follows:

Year ending
March 31,	Amount
2024	$	541,632

Amortization of Debt Discount

During the period ended September 30, 2023, the Company recorded amortization of debt discounts totaling $49,435.

NOTE 7 – NONCONTROLLING INTEREST

Investments in partnerships, joint ventures and less-than-majority-owned subsidiaries in which we have significant influence are accounted for under the equity method.

As of March 31, 2018, the Company’s consolidated financial statements includes a venture for the development of a commercial bottled water operation near Browning, Montana. The new venture will be operated through Spring Hill Water Company, LLC, a Nevada limited liability company (“Spring Hill”). Spring Hill is 49% owned by our newly-formed subsidiary corporation, Humble Water Company, and 51% owned by Doore, LLC. Doore, LLC, which serves as the manager of Spring Hill, has contributed the land and water source to be used in the new operation through a Land & Water Lease Agreement under which Spring Hill will have the use of 2 acres of land and no less than 5 acre-feet of water for an initial term of 25 years and at a lease rate of $1 per year. Through Humble Water Company, our initial capital contribution to Spring Hill was approximately $100,000 to be used in commencing operations. In addition, we have committed to provide additional capital to be used for a bottling facility and equipment, in an amount up to $530,000, within the next 2 years. Should we fail to provide this additional capital within the next 2 years, our ownership percentage in Spring Hill will be reduced from 49% to 20%. Although we hold a minority ownership percentage in Spring Hill, we will have voting control over the company with 75% of the voting membership units. Further, 100% of the losses, expenditures, and deductions from Spring Hill will be allocated to our subsidiary, Humble Water Company. The activity of Spring Hill is accounted for under the voting interest method, and we consolidate 100% of the business activity and record 25% of noncontrolling interest on the balance sheet and 0% of the net losses based on the terms of the agreement.

As of September 30, 2023 and March 31, 2023, the noncontrolling interest was $24,437 in the accompanying condensed consolidated financial statements. As of September 30, 2023 and March 31, 2023, our total investment into Spring Hill to date was $101,470. During the periods ended September 30, 2023 and 2022, there have been no significant operations or expenditures in the joint venture.

F-12

RIGHT ON BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 8 – EARNINGS PER SHARE

FASB ASC Topic 260, “Earnings Per Share,” requires a reconciliation of the numerator and denominator of the basic and diluted earnings (loss) per share (EPS) computations.

Basic earnings (loss) per share are computed by dividing the income available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.

The Company had no potential additional dilutive securities outstanding at September 30, 2023 or March 31, 2023, except as follows:

	September 30, 2023		March 31, 2023
Preferred stock		25,000,000		25,000,000
Convertible debt		1,847,933		720,373
Total		26,847,933		25,720,373

NOTE 9 – STOCKHOLDERS’ EQUITY

Series A Preferred Stock

The Series A Preferred Stock is convertible to common stock at a rate of five shares for every share held and the holder(s) have the right to cast a total of fifty-percent (50%) plus one votes on all matters submitted to a vote of holder of the Company’s common stock. Our Series A Preferred Stock ranks equally, on an as-converted basis, to our common stock with respect to rights upon winding up, dissolution, or liquidation.

On June 6, 2019 the Board of Directors agreed to amend the certificate of designation for the Series A Preferred stock to have the right to cast a total of fifty-percent (50%) plus one votes on all matters submitted to a vote of holder of the Company’s common stock, including the election of directors, and all other matters as required by law. There is no right to cumulative voting in the election of directors. The holders of Series A Preferred Stock shall vote together with all other classes and series of common stock of the Company as a single class on all actions to be taken by the common stock holders of the Company except to the extent that voting as a separate class or series is required by law. Our Series A Preferred Stock does not have any special dividend rights.

Common Stock

During December 2022, the Company’s shareholders approved a reverse split of the Company’s common stock in the amount of 250 for 1. The reverse split was to be effective during January 2023. However, the reverse split was not approved by FINRA until September 2023. The effect of the reverse split has been retroactively presented in these condensed consolidated financial statements.

F-13

RIGHT ON BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 10 – COMMITMENTS AND CONTINGENCIES

On March 17, 2021, the Company entered into a storefront lease agreement in Rowlett, Texas. At the inception of the lease, the Company recorded a right of use asset and lease liability of $93,000, respectively. The Company records rent on straight-line basis over the terms of the underlying lease. Minimum lease payments under the lease are as follows:

Year Ending March 31,	Amount
2024	$	13,358
2025		25,025
Total remaining lease payments	$	38,383
Less: imputed interest		(7,710	)
Present Value of remaining lease payments	$	30,673
Current	$	23,106
Noncurrent	$	7,567
Remaining lease term (years)		1.42
Discount rate		5.00	%

NOTE 11 – SUBSEQUENT EVENTS

On October 16, 2023, the Company entered into a 10% convertible note agreement with proceeds totaling $45,000. The convertible note matures on July 30, 2024 and is convertible into shares of common stock after 180 days at 61% of the lowest trading price of the Company’s common stock during the ten trading days prior to conversion.

F-14

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and related notes thereto included elsewhere in this report. In addition to historical financial information, the following discussion and analysis contains forward-looking statements based upon current expectations that involve risks, uncertainties, and assumptions, such as our plans, objectives, expectations, and intentions. Forward-looking statements are statements not based on historical information and which relate to future operations, strategies, financial results, or other developments. Forward-looking statements are based upon estimates, forecasts, and assumptions that are inherently subject to significant business, economic, and competitive uncertainties, and contingencies, many of which are beyond our control and many of which, with respect to future business decisions, are subject to change. These uncertainties and contingencies can affect actual results and could cause actual results to differ materially from those expressed in any forward-looking statements made by us, or on our behalf. We disclose any obligation to update forward-looking statements. Our actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors. We use words such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “believe,” “intend,” “may,” “will,” “should,” “could,” and similar expressions to identify forward-looking statements.

Overview

Right On Brands is at the intersection of health and wellness. We create lasting brands with emerging functional ingredients, and our focus right now is industrial hemp and hemp derived products. Our business has historically been conducted through our wholly owned subsidiaries, Endo Brands and Humble Water Company. Humble Water Company is in a partnership with Springhill Water Co. to develop a line of High Alkaline, Natural Mineral Water, and a bottling and packaging facility, but it is no longer active. Endo Brands creates and markets a line of cannabinoid-based consumer products. All of our current business is through Endo Brands.

Results of Operations

Three Months Ended September 30, 2023, Compared to the Three Months Ended September 30, 2022:

Revenues

Revenues for the three months ended September 30, 2023, were approximately $329,000, as compared to approximately $241,000 for the three months ended September 30, 2022, an increase of approximately $88,000, or 36%.

This increase in revenues can be attributed to an increase in wholesale revenues, which approximated $34,000 in the current year compared to none in the prior year, combined with improved in store sales. We expect our revenues to improve in future periods as we plan to partner with new locations for wholesaling and expand our offerings.

Gross Profit and Margins

Gross profit for the three months ended September 30, 2023, was approximately $187,000, as compared to approximately $102,000 for the three months ended September 30, 2022. The $85,000 increase, or 83%, in gross profit is the result of the Company’s increased focus on wholesaling and our retail store front focusing on selling more profitable products as compared to sales during the comparative prior period. Gross profit margin for the three months ended September 30, 2023, was approximately 57%, as compared to approximately 42% for the three months ended September 30, 2022. This change in gross profit margin resulted from management identifying and focusing sales efforts on the most popular and highest margin products during 2023. We believe that, subject to factors outside of our control, gross margins of approximately 50% are likely to be the norm.

Operating Expenses

Operating expenses for the three months ended September 30, 2023, were approximately $233,000, as compared to approximately $182,000 for the three months ended September 30, 2022. The increase was primarily due to an increase in staffing. We expect that operating expenses will increase over the next 12-36 months as our long-term growth strategy will require increases in personnel and facility expansion.

4

Profit/Loss from Operations and Total Net Loss

Loss from operations for the three months ended September 30, 2023, was approximately $45,000, as compared to a loss from operations of approximately $80,000 for the three months ended September 30, 2022, a decrease of approximately $35,000. The increase in revenues during the current period was only partially offset by an increase in staffing costs. Management believes the increase in staff will allow revenues to continue to increase.

Total net loss for the three months ended September 30, 2023, was approximately $92,000, as compared to a total net loss of approximately $96,000 for the three months ended September 30, 2022, a change of approximately $4,000. The change for the three months ended September 30, 2023, was as a result of (i) the change in operations discussed above, (ii) interest expenses of approximately $3,000 in the current period compared to approximately $3,000 in the prior period, (iii) amortization of debt discounts of $43,000 in the current period compared to $8,000 in the prior period, (iv) financing costs of $4,250 in the prior period and (vi) non-cash gains of approximately $8 related to the derivative liability compared to non-cash gains of approximately $-0- in the prior period. Derivative liabilities are associated with notes that are convertible and may have variable pricing on the equivalent shares of Common Stock. At the end of each period, these derivative liabilities are valued, and the net change is recorded as a gain or loss in other expense and income.

Six Months Ended September 30, 2023, Compared to the Six Months Ended September 30, 2022:

Revenues

Revenues for the six months ended September 30, 2023, were approximately $735,000, as compared to approximately $549,000 for the six months ended September 30, 2022, an increase of approximately $185,000, or 34%.

This increase in revenues can be attributed to an increase in wholesale revenues, which approximated $149,000 in the current year compared to none in the prior year, combined with improved in store sales. We expect our revenues to improve in future periods as we plan to partner with new locations for wholesaling and expand our offerings.

Gross Profit and Margins

Gross profit for the six months ended September 30, 2023, was approximately $407,000, as compared to approximately $283,000 for the six months ended September 30, 2022. The $124,000 increase, or 44%, in gross profit is the result of the Company’s increased focus on wholesaling and our retail store front focusing on selling more profitable products as compared to sales during the comparative prior period. Gross profit margin for the six months ended September 30, 2023, was approximately 55%, as compared to approximately 52% for the six months ended September 30, 2022. This change in gross profit margin resulted from management identifying and focusing sales efforts on the most popular and highest margin products during 2023. We believe that, subject to factors outside of our control, gross margins of approximately 50% are likely to be the norm.

Operating Expenses

Operating expenses for the six months ended September 30, 2023, were approximately $466,000, as compared to approximately $358,000 for the six months ended September 30, 2022. The increase was primarily due to an increase in staffing. We expect that operating expenses will increase over the next 12-36 months as our long-term growth strategy will require increases in personnel and facility expansion.

5

Profit/Loss from Operations and Total Net Loss

Loss from operations for the six months ended September 30, 2023, was approximately $59,000, as compared to a loss from operations of approximately $75,000 for the six months ended September 30, 2022, a decrease of approximately $16,000. The increase in revenues during the current period was only partially offset by an increase in staffing costs. Management believes the increase in staff will allow revenues to continue to increase.

Total net loss for the six months ended September 30, 2023, was approximately $171,000, as compared to a total net income of approximately $98,000 for the six months ended September 30, 2022, a change of approximately $269,000. The change for the six months ended September 30, 2023, was as a result of (i) the change in operations discussed above, (ii) a gain on settlement of liabilities in the prior period of approximately $140,000, (iii) interest expenses of approximately $21,000 in the current period compared to approximately $6,000 in the prior period, (iv) amortization of debt discounts of $49,000 in the current period compared to $10,000 in the prior period, (v) financing costs of $40,785 in the current period compared to $4,250 in the prior period and (vi) non-cash gains of approximately $160 related to the derivative liability compared to non-cash gains of approximately $52,000 in the prior period. Derivative liabilities are associated with notes that are convertible and have variable pricing on the equivalent shares of Common Stock. At the end of each period, these derivative liabilities are valued, and the net change is recorded as a gain or loss in other expense and income.

We do not expect to realize significant net income in the near term as anticipated operational expenses are expected to increase as our long-term growth strategy will require increases in personnel and facilities. Despite management’s focus on ensuring operating efficiencies, we expect to continue to operate at a loss through fiscal 2024.

Liquidity and Capital Resources

Going Concern

We have incurred significant operating losses since inception and have negative cash flow from operations. As of September 30, 2023, we had an accumulated deficit of approximately $15,932,000, a working capital deficit of approximately $671,000, and incurred net loss of approximately $171,000 for the six months ended September 30, 2023. Additionally, our operations utilized approximately $87,000 in cash during the six months ended September 30, 2023, while we received approximately $74,000 in net cash from financing activities. As a result, our continuation as a going concern is dependent on our ability to obtain additional financing until we can generate sufficient cash flows from operations to meet our obligations. We intend to continue to seek additional debt or equity financing to continue our operations, but there can be no assurance that such financing will be available on terms acceptable to us, if at all.

Our condensed consolidated financial statements have been prepared on a going concern basis, which implies we may not continue to meet our obligations and continue our operations for the next fiscal year. The continuation of our Company as a going concern is dependent upon our ability to obtain necessary debt or equity financing to continue operations until we begin generating positive cash flow.

As of September 30, 2023 and March 31, 2023, we had cash of approximately $20,000 and $33,000, respectively. We estimate our operating expenses for the near- and mid-term may continue to exceed the revenues that we may generate, and we may need to raise capital through either debt or equity offerings to continue operations. We are in the early stages of our business. We are required to fund growth from financing activities, and we intend to rely on a combination of equity and debt financing. Due to market conditions and the early stage of our operations, there is a considerable risk that we will not be able to raise such financing at all, or on terms that are not overly dilutive to our existing stockholders. We can offer no assurance that we will be able to raise such funds. If we are unable to raise the funds we require for all of our planned operations, we may be forced to reallocate funds from other planned uses and may suffer a significant negative effect on our business plan and operations, including our ability to develop new products and continue our current operations. As a result, our business may suffer, and we may be forced to reduce or discontinue operations.

There is no assurance that we will ever be profitable or that debt or equity financing will be available to us in the amounts, on terms, and at times deemed acceptable to us, if at all. The issuance of additional equity securities by us would result in a significant dilution in the equity interests of our current stockholders. Obtaining commercial loans, assuming those loans would be available, would increase our liabilities and future cash commitments. If we are unable to obtain financing in the amounts and on terms deemed acceptable to us, we may be unable to continue our business, as planned, and as a result may be required to scale back or cease operations for our business, the result of which would be that our stockholders would lose some or all of their investment. The condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should we be unable to continue as a going concern.

6

Cash Flows – Operating Activities

For the six months ended September 30, 2023, our cash used in operating activities amounted to an outflow of approximately $87,000, compared to cash used during the six months ended September 30, 2022, of approximately $108,000. The decrease in cash used in our operating activities is due to the Company increasing revenues, partially offset by increased personnel costs.

Cash Flows – Investing Activities

For the six months ended September 30, 2023 and 2022, there was no cash used in investing activities.

Cash Flows – Financing Activities

For the six months ended September 30, 2023, our cash provided by financing activities amounted to approximately $74,000, which includes approximately $63,000 in proceeds from notes payable, $65,000 in proceeds from convertible notes payable, and repayments of notes payable totaling approximately $54,000. Our cash provided by financing activities for the six months ended September 30, 2022, amounted to approximately $92,000, which includes approximately $202,000 in proceeds from notes payable and repayments of notes payable totaling approximately $110,000. The Company anticipates additional financing through the issuance of notes payable and common stock to fund the expansion in operations.

Off Balance Sheet Arrangements

As of September 30, 2023 and March 31, 2023, we had no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to stockholders.

Critical Accounting Policies

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Such estimates and assumptions affect the reported amounts of revenues and expenses during the reporting period. We base our estimates on historical experiences and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ materially from these estimates under different assumptions and conditions. We continue to monitor significant estimates made during the preparation of our financial statements. On an ongoing basis, we evaluate estimates and assumptions based upon historical experience and various other factors and circumstances. We believe our estimates and assumptions are reasonable in the circumstances; however, actual results may differ from these estimates under different future conditions.

There have been no changes from the Summary of Significant Accounting Policies described in our Annual Report on Form 10-K for the year ended March 31, 2023, filed with the Securities and Exchange Commission on August 16, 2023.

7

Item 3. Quantitative and Qualitative Disclosures About Market Risk

A smaller reporting company is not required to provide the information required by this Item.

Item 4. Controls and Procedures

We carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of September 30, 2023. This evaluation was carried out under the supervision and with the participation of our Chief Executive Officer, Jerry Grisaffi. Based upon that evaluation, our Chief Executive Officer concluded that, as of September 30, 2023, our disclosure controls and procedures are not effective. There have been no changes in our internal controls over financial reporting during the period ended September 30, 2023.

Our management identified the following material weaknesses in our internal control over financial reporting, which are indicative of many small companies with small staff: (i) inadequate segregation of duties and effective risk assessment; and (ii) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of both US GAAP and SEC guidelines.

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act are recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Limitations on the Effectiveness of Internal Controls

Our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will necessarily prevent all fraud and material error. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the internal control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, control may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate.

8

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors

A smaller reporting company is not required to include this information. For a description of the risk factors applicable to our business and operations, please refer to our Annual Report on Form 10-K for the year ended March 31, 2023, filed with SEC on August 16, 2023.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

9

Item 6. Exhibits

Exhibit Number	Description of Exhibit
3.1	Articles of Incorporation (incorporated by reference to Registration Statement on Form S-1 filed July 1, 2013)
3.2	Certificate of Designation (incorporated by reference to Current Report on Form 8-K filed October 5, 2016)
3.3	Articles of Merger (changing name) (incorporated by reference to Current Report on Form 8-K filed August 31, 2017)
3.4	Bylaws (incorporated by reference to Registration Statement on Form S-1 filed July 1, 2013)
31.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101	Materials from the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2023 formatted in Extensible Business Reporting Language (XBRL)

10

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Right On Brands, Inc.
Date: November 14, 2023	By:	/s/ Jerry Grisaffi
	Name:	Jerry Grisaffi
	Title:	Chief Executive Officer

Date: November 14, 2023	By:	/s/ Jerry Grisaffi
	Name:	Jerry Grisaffi
	Title:	Chief Financial Officer

11

EX-31.1

EXHIBIT 31.1

CERTIFICATIONS

I, Jerry Grisaffi, certify that;

1. I have reviewed this quarterly report on Form 10-Q of Right On Brands, Inc. (the "registrant");

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 14, 2023
	/s/ Jerry Grisaffi
By:	Jerry Grisaffi
Title:	Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATIONS

I, Jerry Grisaffi, certify that;

1. I have reviewed this quarterly report on Form 10-Q of Right On Brands, Inc. (the "registrant");

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 14, 2023
	/s/ Jerry Grisaffi
By:	Jerry Grisaffi
Title:	Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND

CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly Report of Right On Brands, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2023, filed with the Securities and Exchange Commission (the "Report"), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.	The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented.

By:	/s/ Jerry Grisaffi
Name:	Jerry Grisaffi
Title:	Principal Executive Officer
Date:	November 14, 2023

By:	/s/ Jerry Grisaffi
Name:	Jerry Grisaffi
Title:	Principal Financial Officer
Date:	November 14, 2023

XML

Cover - shares	6 Months Ended
	Sep. 30, 2023	Nov. 14, 2023
Cover [Abstract]
Entity Registrant Name	Right On Brands, Inc.
Entity Central Index Key	0001580262
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Sep. 30, 2023
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2024
Entity Common Stock Shares Outstanding		25,498,064
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Entity File Number	000-55704
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	45-1994478
Entity Address Address Line 1	6501 Dalrock Road
Entity Address Address Line 2	Suite 100
Entity Address City Or Town	Rowlett
Entity Address State Or Province	TX
Entity Address Postal Zip Code	75089
City Area Code	214
Local Phone Number	299-9528

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2023	Mar. 31, 2023
Current assets
Cash	$ 20,299	$ 33,322
Accounts receivable	24,431	1,798
Inventory	136,445	116,115
Other current assets	3,221	3,221
Total current assets	184,396	154,456
Non-current assets
Property and equipment, net of depreciation	7,085	9,885
Right of use asset	30,673	42,488
Total non-current assets	37,758	52,373
Total assets	222,154	206,829
Current liabilities
Accounts payable	87,753	77,388
Accrued interest payable	42,388	28,236
Accrued expenses	107,110	104,148
Unearned revenue	12,500	12,500
Lease liability, current portion	23,106	23,388
Notes payable, net of discount	237,890	257,077
Convertible debt, net of discount	210,240	182,051
Derivative liability	134,312	0
Total current liabilities	855,299	684,788
Lease liability, non-current	7,567	19,100
Total liabilities	862,866	703,888
Stockholders' deficit
Series A Preferred stock; 10,000,000 shares authorized of $.001 par value; 5,000,000 shares issued	5,000	5,000
Common stock; par value $.001; 12,000,000,000 shares authorized, 25,498,064 shares issued	25,498	25,498
Additional paid-in capital	15,221,530	15,194,247
Common stock payable	15,000	15,000
Accumulated deficit	(15,932,177)	(15,761,241)
Total Right On Brands stockholders' deficit	(665,149)	(521,496)
Noncontrolling interest	24,437	24,437
Total stockholders' deficit	(640,712)	(497,059)
Total liabilities and stockholders' deficit	$ 222,154	$ 206,829

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2023	Mar. 31, 2023
CONDENSED CONSOLIDATED BALANCE SHEETS
Common stock, shares par value	$ 0.001	$ 0.001
Common stock, shares authorized	12,000,000,000	12,000,000,000
Common stock, shares issued	25,498,064	25,498,064
Preferred stock, shares par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	5,000,000	5,000,000

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
Revenues	$ 328,914	$ 241,111	$ 734,759	$ 549,465
Cost of goods sold	141,855	138,785	328,030	266,116
Gross profit	187,059	102,326	406,729	283,349
Operating expenses
General and administrative	197,912	144,009	396,097	270,588
Advertising and promotion	9,787	1,164	24,785	7,279
Legal and professional	23,450	35,880	42,482	77,341
Depreciation and amortization	1,400	1,400	2,800	2,800
Total operating expenses	232,549	182,453	466,164	358,008
Loss from operations	(45,490)	(80,127)	(59,435)	(74,659)
Other income and (expense)
Interest expense	(3,110)	(3,407)	(21,442)	(5,875)
Amortization of debt discount	(43,161)	(8,264)	(49,435)	(9,754)
Change in fair value of derivative liability	8	0	161	51,994
Financing costs	0	(4,250)	(40,785)	(4,250)
Gain on settlement of liabilities	0	0	0	140,297
Total other income (expense)	(46,263)	(15,921)	(111,501)	172,412
Net income (loss) including noncontrolling interest	(91,753)	(96,048)	(170,936)	97,753
Net income (loss) attributable to noncontrolling interest	0	0	0	0
Net income (loss) attributable to Right on Brands, Inc.	$ (91,753)	$ (96,048)	$ (170,936)	$ 97,753
Income (loss) per share - basic	$ (0.00)	$ (0.00)	$ (0.01)	$ 0.00
Income (loss) per share - diluted				$ 0.00
Weighted average shares outstanding - basic	25,498,064	23,445,178	25,498,064	23,571,743
Weighted average shares outstanding - diluted				23,710,076

XML

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (UNAUDITED) - USD ($)	Total	Preferred Stock [Member]	Common Stock	Additional Paid-In Capital	Common Stock Payable [Member]	Retained Earnings (Accumulated Deficit)	Noncontrolling Interest
Balance, shares at Mar. 31, 2022		5,000,000	23,699,207
Balance, amount at Mar. 31, 2022	$ (565,928)	$ 5,000	$ 23,699	$ 15,099,083	$ 51,820	$ (15,769,967)	$ 24,437
Issuance of common stock issuable, shares			5,600
Issuance of common stock issuable, amount	0	0	$ 6	36,814	(36,820)	0	0
Recession of shares, shares			(612,456)
Recession of shares, amount	0	0	$ (612)	612	0	0	0
Net income	97,753	$ 0	$ 0	0	0	97,753	0
Balance, shares at Sep. 30, 2022		5,000,000	23,092,351
Balance, amount at Sep. 30, 2022	(468,175)	$ 5,000	$ 23,093	15,136,509	15,000	(15,672,214)	24,437
Balance, shares at Mar. 31, 2023		5,000,000	25,498,064
Balance, amount at Mar. 31, 2023	(497,059)	$ 5,000	$ 25,498	15,194,247	15,000	(15,761,241)	24,437
Net income	(170,936)	0	0	0	0	(170,936)	0
Settlement of derivative liability	27,283	$ 0	$ 0	27,283	0	0	0
Balance, shares at Sep. 30, 2023		5,000,000	25,498,064
Balance, amount at Sep. 30, 2023	$ (640,712)	$ 5,000	$ 25,498	$ 15,221,530	$ 15,000	$ (15,932,177)	$ 24,437

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
OPERATING ACTIVITIES
Net income (loss)	$ (170,936)	$ 97,753
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	2,800	2,800
Amortization of debt discount	49,435	9,754
Financing costs	40,785	4,250
Change in fair value of derivative liability	(161)	(51,994)
Gain on settlement of liabilities	0	(140,297)
Changes in operating assets and liabilities:
Accounts receivable	(22,633)	0
Prepaid expenses	0	(6,000)
Inventory	(20,330)	(41,297)
Accounts payable	10,365	17,476
Accrued interest payable	20,957	5,875
Accrued expenses	2,962	(6,197)
NET CASH USED IN OPERATING ACTIVITIES	(86,756)	(107,877)
INVESTING ACTIVITIES
NET CASH USED IN INVESTING ACTIVITIES	0	0
FINANCING ACTIVITIES
Proceeds from notes payable	63,195	202,101
Proceeds from convertible notes payable	65,000	0
Repayment of notes payable	(54,462)	(109,968)
NET CASH PROVIDED BY FINANCING ACTIVITIES	73,733	92,133
NET DECREASE IN CASH	(13,023)	(15,744)
CASH, BEGINNING OF PERIOD	33,322	28,056
CASH, END OF PERIOD	20,299	12,312
CASH PAID FOR INCOME TAXES	485	0
CASH PAID FOR INTEREST	0	0
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Discount on note payable	14,000	0
Discount on note payable from derivative liability	70,000	0
Discount on convertible note payable from derivative liability	50,971	0
Settlement of derivative liability	27,283	0
Accrued interest settled with note payable	6,805	0
Common stock issued for common stock payable	0	36,820
Principal and interest settled	0	33,185
Original issuance discount on notes payable	$ 0	$ 16,991

XML

ORGANIZATION AND NATURE OF BUSINESS

6 Months Ended

Sep. 30, 2023

ORGANIZATION AND NATURE OF BUSINESS

ORGANIZATION AND NATURE OF BUSINESS

NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS

Formation and Business Activity

Right on Brands, Inc. (“we” or “the Company” or “Right on Brands”) was incorporated under the laws of the State of Nevada on April 1, 2011, as HealthTalk Live, Inc. On August 10, 2017, the Company amended is articles of incorporation and changed its name to Right On Brands, Inc. On August 31, 2017 the Company's common shares commenced trading under the new stock symbol RTON. The Company’s primary business is the sale of health and wellness products.

The Company has the following wholly owned subsidiaries:

· Endo Brands, Inc.

· Humble Water Company

The Company has the following majority owned subsidiaries:

· Endo & Centre Venture LLC (51% owner)

· Spring Hill Water Company, LLC (49% owner – see Note 7)

The Company, through its subsidiaries Humble Water Company and Endo & Centre Venture LLC, had joint ventures with no activity. The Company has discontinued these joint ventures and Humble Water Company and Endo & Centre Venture LLC contain no assets, liabilities, or operations.

On April 16, 2018, the Company entered into an operating agreement with Centre Manufacturing, Inc. (“Centre”) and agreed to form an LLC. The LLC is owned 51% by the Company and 49% owned by Centre, but all income and losses will be split evenly. The owner of Centre is the former CEO of the Company. On June 19, 2018, the Company formed a majority owned subsidiary, Endo & Centre Venture LLC. No significant activity has occurred to date. At September 30, 2023 and March 31, 2023, the Company owed Centre $14,154, respectively, which is included in accounts payable on the accompanying condensed consolidated balance sheets.

The Company continues to sell health and wellness products focused in the hemp marketplace through online and in-person retail sales.

XML

GOING CONCERN

6 Months Ended

Sep. 30, 2023

GOING CONCERN

GOING CONCERN

NOTE 2 – GOING CONCERN

The accompanying condensed consolidated financial statements (the “financial statements" or “consolidated financial statements”) have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. For the period ended September 30, 2023, the Company had an accumulated deficit of approximately $15,932,000, had a net loss of approximately $171,000, and net cash used in operating activities of approximately $87,000, with approximately $735,000 revenue earned, and a lack of profitable operational history. These matters, among others, raise substantial doubt about the Company’s ability to continue as a going concern.

While the Company is attempting to generate greater revenues, the Company’s cash position may not be significant enough to support the Company’s daily operations. Management intends to raise additional funds by way of additional public and/or private offerings of its stock. Management believes that the actions presently being taken to further implement its business plan and generate revenues provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to generate revenues and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate revenues.

The condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

XML

SIGNIFICANT ACCOUNTING POLICIES

6 Months Ended

Sep. 30, 2023

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES

NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) and the interim reporting rules of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s latest Annual Report filed with the SEC on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments (unless otherwise indicated), necessary for a fair presentation of the financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year.

Principles of Consolidation

The condensed consolidated financial statements of the Company include the accounts of Right On Brands, Inc. and its wholly owned subsidiaries and majority owned business (Endo Brands, Inc., Humble Water Company, Springhill Water Co, and Endo & Centre Venture LLC). Intercompany accounts and transactions have been eliminated upon consolidation.

Use of Estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash

For purposes of reporting cash flows, the Company has defined cash and cash equivalents as all cash in banks and highly liquid investments available for current use with an initial maturity of three months or less to be cash equivalents. The Company had no cash equivalents at September 30, 2023 or March 31, 2023.

The Company maintains its cash balances at financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”). The FDIC provides coverage of up to $250,000 per depositor, per financial institution, for the aggregate total of depositors’ interest and non-interest-bearing accounts. The Company has not experienced any losses on these accounts and management does not believe that the Company is exposed to any significant risks.

Accounts Receivable

The Company performs periodic credit evaluations of its customers’ financial condition and extends credit to virtually all of its customers on an uncollateralized basis. Credit losses to date have been insignificant and within management’s expectations. The Company provides an allowance for doubtful accounts that is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. Normal accounts receivable are due 30 to 45 days after the issuance of the invoice. Receivables past due more than 60 days are considered delinquent. Delinquent receivables are evaluated for collectability based on individual credit evaluation and specific circumstances of the customer. As of September 30, 2023, and March 31, 2023, the Company’s allowance for doubtful accounts was $0, respectively. The Company did not write off any accounts receivable against the allowance for doubtful accounts during the periods ended September 30, 2023 and 2022, respectively.

Inventory

Inventories are stated at the lower of cost (average cost) or market (net realizable value). Cost includes materials related to the purchase of finished goods to be sold to retail customers. We regularly review inventory quantities on hand, future purchase commitments with our suppliers, and the estimated utility of our inventory. If our review indicates a reduction in utility below carrying value, we reduce our inventory to a new cost basis through a charge to cost of revenue.

Property and Equipment

Property and equipment are stated at cost. Depreciation is provided by the straight-line method over the useful lives of the related assets, ranging from one to five years.

Recoverability of Long-Lived Assets

The Company's long-lived assets and other assets (consisting of property and equipment) are reviewed for impairment in accordance with the guidance of the FASB ASC 360, "Property, Plant, and Equipment," and FASB ASC 205 "Presentation of Financial Statements". The Company tests for impairment losses on long-lived assets used in operations whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Recoverability of an asset to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. Impairment evaluations involve management's estimates on asset useful lives and future cash flows. Actual useful lives and cash flows could be different from those estimated by management which could have a material effect on our reporting results and financial positions. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals, as considered necessary. Through September 30, 2023, the Company had not experienced impairment losses on its long-lived assets. However, there can be no assurances that demand for the Company's products or services will continue, which could result in an impairment of long-lived assets in the future.

Commitments and Contingencies

Liabilities for loss contingencies arising from claims, assessments, litigation, fines, penalties and other sources are recorded when management assesses that it is probable that a liability has been incurred and the amount can be reasonably estimated.

Share Based Compensation

The Company accounts for equity instruments issued in exchange for the receipt of goods or services from other than employees in accordance with FASB ASC 718, “Compensation – Stock Compensation”. Costs are measured at the estimated fair value of the consideration received or the estimated fair value of the equity instruments issued, whichever is more reliably measurable. The value of equity instruments issued for consideration other than employee services is determined on the earliest of a performance commitment or completion of performance by the provider of goods or services as defined by FASB ASC 718, “Compensation – Stock Compensation”.

Income Taxes

In accordance with FASB ASC 740, "Income Taxes," the Company provides for the recognition of deferred tax assets if realization of such assets is more likely than not. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax basis of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.

In addition, the Company’s management performs an evaluation of all uncertain income tax positions taken or expected to be taken in the course of preparing the Company’s income tax returns to determine whether the income tax positions meet a “more likely than not” standard of being sustained under examination by the applicable taxing authorities. This evaluation is required to be performed for all open tax years, as defined by the various statutes of limitations, for federal and state purposes. If the Company has interest or penalties associated with insufficient taxes paid, such expenses are reported in income tax expense.

Revenue Recognition

We recognize revenue when our performance obligation is satisfied. Our primary performance obligation (the distribution and sales of hemp products) is satisfied upon the shipment or delivery of products to our customers, which is also when control is transferred. The transfer of control of products to our online customers is typically based on sales terms that do not allow for a right of return after 7 days from the date of purchase. The transfer of control of products to our in-store customers is typically based on sales terms that do not allow for a right of return.

Our products are sold for cash with payments received at pickup or before shipping.

During the six months ended September 30, 2023, our revenues consisted of approximately $149,000 in wholesale revenues and $586,000 in retail revenues.

Fair Value Measurement

ASC Topic 820, “Fair Value Measurement”, requires that certain financial instruments be recognized at their fair values at our balance sheet dates. However, other financial instruments, such as debt obligations, are not required to be recognized at their fair values, but GAAP provides an option to elect fair value accounting for these instruments. GAAP requires the disclosure of the fair values of all financial instruments, regardless of whether they are recognized at their fair values or carrying amounts in our balance sheets. For financial instruments recognized at fair value, GAAP requires the disclosure of their fair values by type of instrument, along with other information, including changes in the fair values of certain financial instruments recognized in income or other comprehensive income. For financial instruments not recognized at fair value, the disclosure of their fair values is provided below under “Financial Instruments.”

Nonfinancial assets, such as property, plant and equipment, and nonfinancial liabilities are recognized at their carrying amounts in the Company’s balance sheets. GAAP does not permit nonfinancial assets and liabilities to be remeasured at their fair values. However, GAAP requires the remeasurement of such assets and liabilities to their fair values upon the occurrence of certain events, such as the impairment of property, plant and equipment. In addition, if such an event occurs, GAAP requires the disclosure of the fair value of the asset or liability along with other information, including the gain or loss recognized in income in the period the remeasurement occurred.

Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities;

Level 2 - Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; or

Level 3 - Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).

The Company did not have any Level 1 or Level 2 assets and liabilities at September 30, 2023 and 2022. The Derivative liabilities are Level 3 fair value measurements.

The following is a summary of activity of Level 3 liabilities during the period ended September 30, 2023:

Balance - March 31, 2023	$	-
Additions		161,756
Settlements		(27,283	)
Change in fair value		(161	)
Balance - September 30, 2023	$	134,312

The following is a summary of activity of Level 3 liabilities during the period ended September 30, 2022:

Balance at March 31, 2022	$	159,106
Settlement		(107,112	)
Change in fair value		(51,994	)
Balance at September 30, 2022	$	-

Under the Company’s contract ordering policy, the Company first considers common shares issued and outstanding as well as reserved but unissued equity awards, such as under an equity award program. All remaining equity linked instruments such as, but not limited to, options, warrants, and debt and equity with conversion features are evaluated based on the date of issuance. If the number of shares which may be issued under the Company’s agreements exceed the authorized number of shares or are unable to be determined, equity linked instruments from that date forward are considered to be derivative liabilities until such time as the number of shares which may be issued under the Company’s agreements no longer exceed the authorized number of shares and are able to be determined.

On June 22, 2023, the Company issued a note payable agreement which contained default provisions that included a conversion feature meeting the definition of a derivative liability which therefore required bifurcation.

At September 30, 2023, the Company estimated the fair value of the conversion feature derivatives embedded in note payable agreements based on assumptions used in the Cox-Ross-Rubinstein binomial pricing model using the following inputs: the price of the Company’s common stock of $0.014; risk-free interest rates ranging from 5.56% to 5.61%, and expected volatility of the Company’s common stock ranging from 476% to 563%, estimated exercise prices ranging from $0.007575 to $0.025, and terms under one year.

Financial Instruments

The Company’s financial instruments include cash and cash equivalents, receivables, payables, and debt and are accounted for under the provisions of ASC Topic 825, “Financial Instruments”. The carrying amount of these financial instruments, with the exception of discounted debt, as reflected in the consolidated balance sheets approximates fair value.

Convertible Instruments

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815 “Derivatives and Hedging Activities”.

Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. Proceeds from these convertible notes are reported under the financing section of the statements of cash flows. Changes to the fair value of the derivative liability are reported as adjustments to reconcile net loss to net cash used in operating activities in the accompanying statement of cash flows.

Basic and Diluted Loss Per Share

Basic net loss/income per common share is computed using the weighted average number of common shares outstanding. Diluted earnings per share (EPS) include additional dilution from common stock equivalents, such as stock issuable pursuant to the exercise of stock options, warrants and convertible notes. Common stock equivalents are not included in the computation of diluted earnings per share when the Company reports a loss because to do so would be anti-dilutive for periods presented.

Recently Issued Accounting Standards

During the period ended September 30, 2023, and subsequently, there were several new accounting pronouncements issued by the FASB. Each of these pronouncements, as applicable, has been or will be adopted by the Company. Management does not believe the adoption of any of these accounting pronouncements has had or will have a material impact on the Company’s condensed consolidated financial statements.

Subsequent Events

The Company has evaluated all transactions through the date the condensed  consolidated financial statements were issued for subsequent event disclosure consideration.

XML

INVENTORY

6 Months Ended

Sep. 30, 2023

INVENTORY

INVENTORY

NOTE 4 – INVENTORY

The Company’s inventory consisted of the following at the respective balance sheet dates:

	September 30, 2023		March 31, 2023
Finished goods	$	136,445	$	116,115
	$	136,445	$	116,115

XML

PROPERTY AND EQUIPMENT AND INTANGIBLE ASSETS

6 Months Ended

Sep. 30, 2023

PROPERTY AND EQUIPMENT AND INTANGIBLE ASSETS

PROPERTY AND EQUIPMENT AND INTANGIBLE ASSETS

NOTE 5 – PROPERTY AND EQUIPMENT AND INTANGIBLE ASSETS

The Company’s property and equipment consisted of the following at the respective balance sheet dates:

	September 30, 2023			March 31, 2023
Website development	$	88,965		$	88,965
Automobile		-			31,596
Studio and office equipment		11,910			11,910
Tenant improvements		11,135			11,135
Intangible assets		1,024			1,024
		113,034			144,630
Accumulated depreciation and amortization		(105,949	)		(134,745	)
	$	7,085		$	9,885

Depreciation expense of property and equipment for the periods ended September 30, 2023 and 2022 was $2,800, respectively.

XML

DEBT

6 Months Ended

Sep. 30, 2023

DEBT

DEBT

NOTE 6 – DEBT

Notes Payable

On November 22, 2019, the Company issued a $50,000 promissory note to a third-party lender for a $25,000 cash borrowing. Accordingly, a $25,000 discount was recorded at issuance, all of which was amortized by March 31, 2020. The non-interest-bearing note is secured by inventory, matured February 20, 2020, and remains in default at September 30, 2023.

During December 2021, the Company was listed as defendant on a complaint from Noteholder 10 seeking repayment of amounts due under a February 2020 convertible note payable. The Company has recorded all unpaid principal and interest due to Noteholder 10 through March 31, 2022. On April 15, 2022, the Company and Noteholder 10 entered into a settlement agreement whereby the Company will repay Noteholder 10 a total of $115,000 consisting of $25,000 paid on April 18, 2022, $5,000 to be paid monthly from May 15, 2022 to October 15, 2022, $6,250 to be paid monthly from November 15, 2022 to April 15, 2023, and $7,500 to be paid monthly from May 15, 2023 to July 15, 2023. As a result of the settlement, the Company reclassified the note from convertible debt to notes payable. On September 30, 2023, the balance of the note totaled $60,000 and payments are past due.

On July 21, 2022, the Company entered into a note payable agreement totaling $89,581, consisting of cash proceeds totaling $72,101, repayment of a prior loan balance totaling $6,999, and loan fees totaling $10,481. The note is to be repaid on an ongoing basis by deducting 19.75% of daily sales and applying against the loan balance. The note matures on January 21, 2024. On September 30, 2023, the balance of the note totaled $51,702.

On August 4, 2022, the Company entered into a note payable agreement for $80,000 received as advances during the three months ended September 30, 2022. The note is to be repaid in $3,000 monthly installments beginning on September 10, 2022, with the remaining balance due at maturity on December 31, 2022. On September 30, 2023, the balance of the note totaled $69,786 and was in default.

On August 11, 2022, the Company entered into a 12% note payable agreement totaling $60,760, consisting of cash proceeds totaling $50,000, financing costs of $4,250, and an original discount totaling $6,510. The note requires monthly payments of $6,805 beginning on September 30, 2022 until maturity on August 11, 2023. The note was repaid during June 2023.

On June 22, 2023, the Company entered into a 12% note payable agreement totaling $84,000, consisting of cash proceeds totaling $63,195, financing costs of $5,000, an original discount totaling $9,000, and accrued interest from the August 11, 2022 note totaling $6,805. The note requires monthly payments of $10,453 beginning on July 30, 2023 until maturity on March 30, 2023. Interest at 12% was accrued at issuance. On September 30, 2023, the balance of the note totaled $63,093.

During the period ended September 30, 2023, the Company incurred $21,442 in interest expenses related to notes payable.

Convertible Debt

At September 30, 2023, the Company's convertible debt related to the notes which can be converted at fixed conversion rates are summarized as follows: 

Noteholder	Origination	Maturity	Interest rate		Fixed conversion rate	Principal balance		Debt discount		Net amount of liabilities presented
Noteholder 8	9/5/2023	12/5/2023		8.00%	$0.025/Share	$	65,000	$	36,811	$	28,189
Noteholder 9	7/7/2016	9/30/2019		6.00%	$25.00/Share		25,000		-		25,000
Noteholder 13	2/16/2021	8/16/2021		6.00%	$3.75/Share		140,000		-		140,000
Noteholder 17	2/17/2023	8/20/2023		6.00%	$0.025/Share		17,051		-		17,051
						$	247,051	$	36,811	$	210,240

At March 31, 2023, the Company's convertible debt related to the notes which can be converted at fixed conversion rates are summarized as follows: 

Noteholder	Origination	Maturity	Interest rate		Fixed conversion rate	Principal balance		Debt discount		Net amount of liabilities presented
Noteholder 9	7/7/2016	9/30/2019		6.00%	$25.00/Share	$	25,000	$	-	$	25,000
Noteholder 13	2/16/2021	8/16/2021		6.00%	$3.75/Share		140,000		-		140,000
Noteholder 17	2/17/2023	8/20/2023		6.00%	$0.025/Share		17,051		-		17,051
						$	182,051	$	-	$	182,051

During the period ended September 30, 2023, the Company incurred interest expenses related to convertible debt totaling $5,833.

The convertible debt held by noteholders 9, 13 and 17 were in default at September 30, 2023.

Noteholder 8 and Noteholder 17 are related parties. Noteholder 8 is the daughter of the Company’s CEO and Noteholder 17 is an entity controlled by family members of the Company’s CEO.

Future Maturities

The Company’s future maturities of notes payable and convertible debt are as follows:

Year ending
March 31,	Amount
2024	$	541,632

Amortization of Debt Discount

During the period ended September 30, 2023, the Company recorded amortization of debt discounts totaling $49,435.

XML

NONCONTROLLING INTEREST

6 Months Ended

Sep. 30, 2023

NONCONTROLLING INTEREST

NONCONTROLLING INTEREST

NOTE 7 – NONCONTROLLING INTEREST

Investments in partnerships, joint ventures and less-than-majority-owned subsidiaries in which we have significant influence are accounted for under the equity method.

As of March 31, 2018, the Company’s consolidated financial statements includes a venture for the development of a commercial bottled water operation near Browning, Montana. The new venture will be operated through Spring Hill Water Company, LLC, a Nevada limited liability company (“Spring Hill”). Spring Hill is 49% owned by our newly-formed subsidiary corporation, Humble Water Company, and 51% owned by Doore, LLC. Doore, LLC, which serves as the manager of Spring Hill, has contributed the land and water source to be used in the new operation through a Land & Water Lease Agreement under which Spring Hill will have the use of 2 acres of land and no less than 5 acre-feet of water for an initial term of 25 years and at a lease rate of $1 per year. Through Humble Water Company, our initial capital contribution to Spring Hill was approximately $100,000 to be used in commencing operations. In addition, we have committed to provide additional capital to be used for a bottling facility and equipment, in an amount up to $530,000, within the next 2 years. Should we fail to provide this additional capital within the next 2 years, our ownership percentage in Spring Hill will be reduced from 49% to 20%. Although we hold a minority ownership percentage in Spring Hill, we will have voting control over the company with 75% of the voting membership units. Further, 100% of the losses, expenditures, and deductions from Spring Hill will be allocated to our subsidiary, Humble Water Company. The activity of Spring Hill is accounted for under the voting interest method, and we consolidate 100% of the business activity and record 25% of noncontrolling interest on the balance sheet and 0% of the net losses based on the terms of the agreement.

As of September 30, 2023 and March 31, 2023, the noncontrolling interest was $24,437 in the accompanying condensed consolidated financial statements. As of September 30, 2023 and March 31, 2023, our total investment into Spring Hill to date was $101,470. During the periods ended September 30, 2023 and 2022, there have been no significant operations or expenditures in the joint venture.

XML

EARNINGS PER SHARE

6 Months Ended

Sep. 30, 2023

EARNINGS PER SHARE

EARNINGS PER SHARE

NOTE 8 – EARNINGS PER SHARE

FASB ASC Topic 260, “Earnings Per Share,” requires a reconciliation of the numerator and denominator of the basic and diluted earnings (loss) per share (EPS) computations.

Basic earnings (loss) per share are computed by dividing the income available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.

The Company had no potential additional dilutive securities outstanding at September 30, 2023 or March 31, 2023, except as follows:

	September 30, 2023		March 31, 2023
Preferred stock		25,000,000		25,000,000
Convertible debt		1,847,933		720,373
Total		26,847,933		25,720,373

XML

STOCKHOLDERS EQUITY

6 Months Ended

Sep. 30, 2023

STOCKHOLDERS EQUITY

STOCKHOLDERS' EQUITY

NOTE 9 – STOCKHOLDERS’ EQUITY

Series A Preferred Stock

The Series A Preferred Stock is convertible to common stock at a rate of five shares for every share held and the holder(s) have the right to cast a total of fifty-percent (50%) plus one votes on all matters submitted to a vote of holder of the Company’s common stock. Our Series A Preferred Stock ranks equally, on an as-converted basis, to our common stock with respect to rights upon winding up, dissolution, or liquidation.

On June 6, 2019 the Board of Directors agreed to amend the certificate of designation for the Series A Preferred stock to have the right to cast a total of fifty-percent (50%) plus one votes on all matters submitted to a vote of holder of the Company’s common stock, including the election of directors, and all other matters as required by law. There is no right to cumulative voting in the election of directors. The holders of Series A Preferred Stock shall vote together with all other classes and series of common stock of the Company as a single class on all actions to be taken by the common stock holders of the Company except to the extent that voting as a separate class or series is required by law. Our Series A Preferred Stock does not have any special dividend rights.

Common Stock

During December 2022, the Company’s shareholders approved a reverse split of the Company’s common stock in the amount of 250 for 1. The reverse split was to be effective during January 2023. However, the reverse split was not approved by FINRA until September 2023. The effect of the reverse split has been retroactively presented in these condensed consolidated financial statements.

XML

COMMITMENTS AND CONTINGENCIES

6 Months Ended

Sep. 30, 2023

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

NOTE 10 – COMMITMENTS AND CONTINGENCIES

On March 17, 2021, the Company entered into a storefront lease agreement in Rowlett, Texas. At the inception of the lease, the Company recorded a right of use asset and lease liability of $93,000, respectively. The Company records rent on straight-line basis over the terms of the underlying lease. Minimum lease payments under the lease are as follows:

Year Ending March 31,	Amount
2024	$	13,358
2025		25,025
Total remaining lease payments	$	38,383
Less: imputed interest		(7,710	)
Present Value of remaining lease payments	$	30,673
Current	$	23,106
Noncurrent	$	7,567
Remaining lease term (years)		1.42
Discount rate		5.00	%

XML

SUBSEQUENT EVENTS

6 Months Ended

Sep. 30, 2023

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS

NOTE 11 – SUBSEQUENT EVENTS

On October 16, 2023, the Company entered into a 10% convertible note agreement with proceeds totaling $45,000. The convertible note matures on July 30, 2024 and is convertible into shares of common stock after 180 days at 61% of the lowest trading price of the Company’s common stock during the ten trading days prior to conversion.

XML

SIGNIFICANT ACCOUNTING POLICIES (Policies)

6 Months Ended

Sep. 30, 2023

SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) and the interim reporting rules of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s latest Annual Report filed with the SEC on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments (unless otherwise indicated), necessary for a fair presentation of the financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year.

Principles of Consolidation

The condensed consolidated financial statements of the Company include the accounts of Right On Brands, Inc. and its wholly owned subsidiaries and majority owned business (Endo Brands, Inc., Humble Water Company, Springhill Water Co, and Endo & Centre Venture LLC). Intercompany accounts and transactions have been eliminated upon consolidation.

Use of Estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash

For purposes of reporting cash flows, the Company has defined cash and cash equivalents as all cash in banks and highly liquid investments available for current use with an initial maturity of three months or less to be cash equivalents. The Company had no cash equivalents at September 30, 2023 or March 31, 2023.

The Company maintains its cash balances at financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”). The FDIC provides coverage of up to $250,000 per depositor, per financial institution, for the aggregate total of depositors’ interest and non-interest-bearing accounts. The Company has not experienced any losses on these accounts and management does not believe that the Company is exposed to any significant risks.

Accounts Receivable

The Company performs periodic credit evaluations of its customers’ financial condition and extends credit to virtually all of its customers on an uncollateralized basis. Credit losses to date have been insignificant and within management’s expectations. The Company provides an allowance for doubtful accounts that is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. Normal accounts receivable are due 30 to 45 days after the issuance of the invoice. Receivables past due more than 60 days are considered delinquent. Delinquent receivables are evaluated for collectability based on individual credit evaluation and specific circumstances of the customer. As of September 30, 2023, and March 31, 2023, the Company’s allowance for doubtful accounts was $0, respectively. The Company did not write off any accounts receivable against the allowance for doubtful accounts during the periods ended September 30, 2023 and 2022, respectively.

Inventory

Inventories are stated at the lower of cost (average cost) or market (net realizable value). Cost includes materials related to the purchase of finished goods to be sold to retail customers. We regularly review inventory quantities on hand, future purchase commitments with our suppliers, and the estimated utility of our inventory. If our review indicates a reduction in utility below carrying value, we reduce our inventory to a new cost basis through a charge to cost of revenue.

Property and Equipment

Property and equipment are stated at cost. Depreciation is provided by the straight-line method over the useful lives of the related assets, ranging from one to five years.

Recoverability of Long-Lived Assets

The Company's long-lived assets and other assets (consisting of property and equipment) are reviewed for impairment in accordance with the guidance of the FASB ASC 360, "Property, Plant, and Equipment," and FASB ASC 205 "Presentation of Financial Statements". The Company tests for impairment losses on long-lived assets used in operations whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Recoverability of an asset to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. Impairment evaluations involve management's estimates on asset useful lives and future cash flows. Actual useful lives and cash flows could be different from those estimated by management which could have a material effect on our reporting results and financial positions. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals, as considered necessary. Through September 30, 2023, the Company had not experienced impairment losses on its long-lived assets. However, there can be no assurances that demand for the Company's products or services will continue, which could result in an impairment of long-lived assets in the future.

Commitments and Contingencies

Liabilities for loss contingencies arising from claims, assessments, litigation, fines, penalties and other sources are recorded when management assesses that it is probable that a liability has been incurred and the amount can be reasonably estimated.

Share Based Compensation

The Company accounts for equity instruments issued in exchange for the receipt of goods or services from other than employees in accordance with FASB ASC 718, “Compensation – Stock Compensation”. Costs are measured at the estimated fair value of the consideration received or the estimated fair value of the equity instruments issued, whichever is more reliably measurable. The value of equity instruments issued for consideration other than employee services is determined on the earliest of a performance commitment or completion of performance by the provider of goods or services as defined by FASB ASC 718, “Compensation – Stock Compensation”.

Income Taxes

In accordance with FASB ASC 740, "Income Taxes," the Company provides for the recognition of deferred tax assets if realization of such assets is more likely than not. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax basis of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.

In addition, the Company’s management performs an evaluation of all uncertain income tax positions taken or expected to be taken in the course of preparing the Company’s income tax returns to determine whether the income tax positions meet a “more likely than not” standard of being sustained under examination by the applicable taxing authorities. This evaluation is required to be performed for all open tax years, as defined by the various statutes of limitations, for federal and state purposes. If the Company has interest or penalties associated with insufficient taxes paid, such expenses are reported in income tax expense.

Revenue Recognition

We recognize revenue when our performance obligation is satisfied. Our primary performance obligation (the distribution and sales of hemp products) is satisfied upon the shipment or delivery of products to our customers, which is also when control is transferred. The transfer of control of products to our online customers is typically based on sales terms that do not allow for a right of return after 7 days from the date of purchase. The transfer of control of products to our in-store customers is typically based on sales terms that do not allow for a right of return.

Our products are sold for cash with payments received at pickup or before shipping.

During the six months ended September 30, 2023, our revenues consisted of approximately $149,000 in wholesale revenues and $586,000 in retail revenues.

Fair Value Measurement

ASC Topic 820, “Fair Value Measurement”, requires that certain financial instruments be recognized at their fair values at our balance sheet dates. However, other financial instruments, such as debt obligations, are not required to be recognized at their fair values, but GAAP provides an option to elect fair value accounting for these instruments. GAAP requires the disclosure of the fair values of all financial instruments, regardless of whether they are recognized at their fair values or carrying amounts in our balance sheets. For financial instruments recognized at fair value, GAAP requires the disclosure of their fair values by type of instrument, along with other information, including changes in the fair values of certain financial instruments recognized in income or other comprehensive income. For financial instruments not recognized at fair value, the disclosure of their fair values is provided below under “Financial Instruments.”

Nonfinancial assets, such as property, plant and equipment, and nonfinancial liabilities are recognized at their carrying amounts in the Company’s balance sheets. GAAP does not permit nonfinancial assets and liabilities to be remeasured at their fair values. However, GAAP requires the remeasurement of such assets and liabilities to their fair values upon the occurrence of certain events, such as the impairment of property, plant and equipment. In addition, if such an event occurs, GAAP requires the disclosure of the fair value of the asset or liability along with other information, including the gain or loss recognized in income in the period the remeasurement occurred.

Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities;

Level 2 - Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; or

Level 3 - Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).

The Company did not have any Level 1 or Level 2 assets and liabilities at September 30, 2023 and 2022. The Derivative liabilities are Level 3 fair value measurements.

The following is a summary of activity of Level 3 liabilities during the period ended September 30, 2023:

Balance - March 31, 2023	$	-
Additions		161,756
Settlements		(27,283	)
Change in fair value		(161	)
Balance - September 30, 2023	$	134,312

The following is a summary of activity of Level 3 liabilities during the period ended September 30, 2022:

Balance at March 31, 2022	$	159,106
Settlement		(107,112	)
Change in fair value		(51,994	)
Balance at September 30, 2022	$	-

Under the Company’s contract ordering policy, the Company first considers common shares issued and outstanding as well as reserved but unissued equity awards, such as under an equity award program. All remaining equity linked instruments such as, but not limited to, options, warrants, and debt and equity with conversion features are evaluated based on the date of issuance. If the number of shares which may be issued under the Company’s agreements exceed the authorized number of shares or are unable to be determined, equity linked instruments from that date forward are considered to be derivative liabilities until such time as the number of shares which may be issued under the Company’s agreements no longer exceed the authorized number of shares and are able to be determined.

On June 22, 2023, the Company issued a note payable agreement which contained default provisions that included a conversion feature meeting the definition of a derivative liability which therefore required bifurcation.

At September 30, 2023, the Company estimated the fair value of the conversion feature derivatives embedded in note payable agreements based on assumptions used in the Cox-Ross-Rubinstein binomial pricing model using the following inputs: the price of the Company’s common stock of $0.014; risk-free interest rates ranging from 5.56% to 5.61%, and expected volatility of the Company’s common stock ranging from 476% to 563%, estimated exercise prices ranging from $0.007575 to $0.025, and terms under one year.

Financial Instruments

The Company’s financial instruments include cash and cash equivalents, receivables, payables, and debt and are accounted for under the provisions of ASC Topic 825, “Financial Instruments”. The carrying amount of these financial instruments, with the exception of discounted debt, as reflected in the consolidated balance sheets approximates fair value.

Convertible Instruments

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815 “Derivatives and Hedging Activities”.

Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. Proceeds from these convertible notes are reported under the financing section of the statements of cash flows. Changes to the fair value of the derivative liability are reported as adjustments to reconcile net loss to net cash used in operating activities in the accompanying statement of cash flows.

Basic and Diluted Loss Per Share

Basic net loss/income per common share is computed using the weighted average number of common shares outstanding. Diluted earnings per share (EPS) include additional dilution from common stock equivalents, such as stock issuable pursuant to the exercise of stock options, warrants and convertible notes. Common stock equivalents are not included in the computation of diluted earnings per share when the Company reports a loss because to do so would be anti-dilutive for periods presented.

Recently Issued Accounting Standards

During the period ended September 30, 2023, and subsequently, there were several new accounting pronouncements issued by the FASB. Each of these pronouncements, as applicable, has been or will be adopted by the Company. Management does not believe the adoption of any of these accounting pronouncements has had or will have a material impact on the Company’s condensed consolidated financial statements.

Subsequent Events

The Company has evaluated all transactions through the date the condensed  consolidated financial statements were issued for subsequent event disclosure consideration.

XML

SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Sep. 30, 2023

SIGNIFICANT ACCOUNTING POLICIES

Summary of activity of derivative liabilities

Balance - March 31, 2023	$	-
Additions		161,756
Settlements		(27,283	)
Change in fair value		(161	)
Balance - September 30, 2023	$	134,312

Balance at March 31, 2022	$	159,106
Settlement		(107,112	)
Change in fair value		(51,994	)
Balance at September 30, 2022	$	-

XML

INVENTORY (Tables)

6 Months Ended

Sep. 30, 2023

INVENTORY

Schedule of Inventory

	September 30, 2023		March 31, 2023
Finished goods	$	136,445	$	116,115
	$	136,445	$	116,115

XML

PROPERTY AND EQUIPMENT AND INTANGIBLE ASSETS (Tables)

6 Months Ended

Sep. 30, 2023

PROPERTY AND EQUIPMENT AND INTANGIBLE ASSETS

Schedule of property And Equipment

	September 30, 2023			March 31, 2023
Website development	$	88,965		$	88,965
Automobile		-			31,596
Studio and office equipment		11,910			11,910
Tenant improvements		11,135			11,135
Intangible assets		1,024			1,024
		113,034			144,630
Accumulated depreciation and amortization		(105,949	)		(134,745	)
	$	7,085		$	9,885

XML

DEBT (Tables)

6 Months Ended

12 Months Ended

Sep. 30, 2023

Mar. 31, 2023

DEBT

Shedule of convertible debt and derivative liability, June 30, 2022

Noteholder	Origination	Maturity	Interest rate		Fixed conversion rate	Principal balance		Debt discount		Net amount of liabilities presented
Noteholder 8	9/5/2023	12/5/2023		8.00%	$0.025/Share	$	65,000	$	36,811	$	28,189
Noteholder 9	7/7/2016	9/30/2019		6.00%	$25.00/Share		25,000		-		25,000
Noteholder 13	2/16/2021	8/16/2021		6.00%	$3.75/Share		140,000		-		140,000
Noteholder 17	2/17/2023	8/20/2023		6.00%	$0.025/Share		17,051		-		17,051
						$	247,051	$	36,811	$	210,240

Noteholder	Origination	Maturity	Interest rate		Fixed conversion rate	Principal balance		Debt discount		Net amount of liabilities presented
Noteholder 9	7/7/2016	9/30/2019		6.00%	$25.00/Share	$	25,000	$	-	$	25,000
Noteholder 13	2/16/2021	8/16/2021		6.00%	$3.75/Share		140,000		-		140,000
Noteholder 17	2/17/2023	8/20/2023		6.00%	$0.025/Share		17,051		-		17,051
						$	182,051	$	-	$	182,051

Schedule of debt future maturities

Year ending
March 31,	Amount
2024	$	541,632

XML

EARNING PER SHARE (Tables)

6 Months Ended

Sep. 30, 2023

EARNINGS PER SHARE

Summary of dilutive securities

	September 30, 2023		March 31, 2023
Preferred stock		25,000,000		25,000,000
Convertible debt		1,847,933		720,373
Total		26,847,933		25,720,373

XML

COMMITMENTS AND CONTINGENCIES (Tables)

6 Months Ended

Sep. 30, 2023

COMMITMENTS AND CONTINGENCIES

Summary of Minimum lease payments

Year Ending March 31,	Amount
2024	$	13,358
2025		25,025
Total remaining lease payments	$	38,383
Less: imputed interest		(7,710	)
Present Value of remaining lease payments	$	30,673
Current	$	23,106
Noncurrent	$	7,567
Remaining lease term (years)		1.42
Discount rate		5.00	%

XML

ORGANIZATION AND NATURE OF BUSINESS (Details Narrative) - USD ($)	Sep. 30, 2023	Mar. 31, 2023
Accounts payable	$ 87,753	$ 77,388
Endo & Centre Venture LLC [Member]
Ownership percentage	51.00%
Accounts payable	$ 14,154	$ 14,154
Spring Hill Water Company, LLC [Member]
Ownership percentage	49.00%

XML

GOING CONCERN (Details Narrative)	6 Months Ended
	Sep. 30, 2023 USD ($)
GOING CONCERN
Accumulated deficit	$ 15,932,000
Net income	171,000
Net cash used in operating activities	87,000
Revenue	$ 735,000

XML

SIGNIFICANT ACCOUNTING POLICIES (Details) - Fair Value Inputs Level 3 Member - USD ($)	6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Derivative Liability, Begin	$ 0	$ 159,106
Additions	161,756
Settlement	(27,283)	(107,112)
Change in fair value	(161)	(51,994)
Derivative Liability, End	$ 134,312	$ 0

XML

SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Mar. 31, 2023
Revenues	$ 328,914	$ 241,111	$ 734,759	$ 549,465
Accounts receivables, average collection period, description			Normal accounts receivable are due 30 to 45 days after the issuance of the invoice. Receivables past due more than 60 days are considered delinquent
Allowance for doubtful accounts	0		$ 0		$ 0
Cash, FDIC Insured Amount	$ 250,000		$ 250,000
Derivative liability of convertible notes [Member]
Property, Plant and Equipment, Useful Life			1 year
Common stock price per share	$ 0.014		$ 0.014
Derivative liability of convertible notes [Member] | Minimum [Member]
Exercise price	0.007575		$ 0.007575
Expected volatility rate			476.00%
Risk free interest rate			5.56%
Derivative liability of convertible notes [Member] | Maximum [Member]
Exercise price	$ 0.025		$ 0.025
Expected volatility rate			563.00%
Risk free interest rate			5.61%
Wholesale revenues
Revenues			$ 149,000
Retail revenues
Revenues			$ 586,000

XML

INVENTORY (Details) - USD ($)	Sep. 30, 2023	Mar. 31, 2023
INVENTORY
Finished Goods	$ 136,445	$ 116,115
Inventory	$ 136,445	$ 116,115

XML

PROPERTY AND EQUIPMENT AND INTANGIBLE ASSETS (Details) - USD ($)	Sep. 30, 2023	Mar. 31, 2023
Property and equipment, gross	$ 113,034	$ 144,630
Accumulated depreciation and amortization	(105,949)	(134,745)
Property and equipment, net	7,085	9,885
Website development [Member]
Property and equipment, gross	88,965	88,965
Automobile [Member]
Property and equipment, gross	0	31,596
Studio and office equipment [Member]
Property and equipment, gross	11,910	11,910
Tenant Improvements [Member]
Property and equipment, gross	11,135	11,135
Intangible assets [Member]
Property and equipment, gross	$ 1,024	$ 1,024

XML

PROPERTY AND EQUIPMENT AND INTANGIBLE ASSETS (Details Narrative) - USD ($)	6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
PROPERTY AND EQUIPMENT AND INTANGIBLE ASSETS
Depreciation expense	$ 2,800	$ 2,800

XML

DEBT (Details) - USD ($)	6 Months Ended	12 Months Ended
	Sep. 30, 2023	Mar. 31, 2023
Note amount	$ 247,051	$ 182,051
Net amounts of liabilities presented	210,240	182,051
Debt discount	36,811	0
Noteholder 9 [Member]
Debt discount	$ 0	$ 0
Interest rate	6.00%	6.00%
Originations date	Jul. 07, 2016	Jul. 07, 2016
Date due	Sep. 30, 2019	Sep. 30, 2019
Fixed conversion rate	$ 25.00	$ 25
Note amounts	$ 25,000	$ 25,000
Net amounts of liabilities presented	25,000	25,000
Noteholder 13 [Member]
Debt discount	$ 0	$ 0
Interest rate	6.00%	6.00%
Originations date	Feb. 16, 2021	Feb. 16, 2021
Date due	Aug. 16, 2021	Aug. 16, 2021
Fixed conversion rate	$ 3.75	$ 3.75
Note amounts	$ 140,000	$ 140,000
Net amounts of liabilities presented	140,000	140,000
Noteholder 17 [Member]
Debt discount	$ 0	$ 0
Interest rate	6.00%	6.00%
Originations date	Feb. 17, 2023	Feb. 17, 2023
Date due	Aug. 20, 2023	Aug. 20, 2023
Fixed conversion rate	$ 0.025	$ 0.025
Note amounts	$ 17,051	$ 17,051
Net amounts of liabilities presented	17,051	$ 17,051
Noteholder 8 [Member]
Debt discount	$ 36,811
Interest rate	8.00%
Originations date	Sep. 05, 2023
Date due	Dec. 05, 2023
Fixed conversion rate	$ 0.025
Note amounts	$ 65,000
Net amounts of liabilities presented	$ 28,189

XML

DEBT (Details 1)	Sep. 30, 2023 USD ($)
2024 [Member]
Future Maturities	$ 541,632

XML

DEBT (Details Narrative) - USD ($)			1 Months Ended			2 Months Ended	5 Months Ended		6 Months Ended
	Aug. 11, 2022	Aug. 04, 2022	Jun. 22, 2023	Jul. 21, 2022	Nov. 22, 2019	Jul. 15, 2023	Apr. 15, 2023	Oct. 15, 2022	Sep. 30, 2023	Sep. 30, 2022	Apr. 18, 2022	Apr. 15, 2022
Amortization of Debt Issuance Costs and Discounts									$ 49,435	$ 9,754
Interest expenses related to Notes Payable									21,442
Proceeds from issuance of debt									65,000	0
Notes Payable Balance									63,195	$ 202,101
Agreement 4 August'2022 [Member]
Monthly payment		$ 3,000
Loan agreement, amount		80,000
Notes Payable Balance		$ 69,786
Maturity date		Dec. 31, 2022
Agreement 21 July'2022 [Member]
Loan agreement, amount				$ 89,581
Proceeds from loan agreement				72,101
Notes Payable Balance				6,999					51,702
Loan Fees				$ 10,481
Maturity date				Jan. 21, 2024
Percentage of daily sales				19.75%
Agreement 11 August'2022 [Member]
Loan agreement, amount	$ 60,760
Proceeds from loan agreement	$ 50,000
Maturity date	Aug. 11, 2023
Percentage Of Note Payable	12.00%
Financing Cost	$ 4,250
Discount Totalling	6,510
Monthly Payment	$ 6,805
Agreement 22 June' 2023 [Member]
Loan agreement, amount			$ 84,000
Proceeds from loan agreement			$ 63,195
Notes Payable Balance									63,093
Maturity date			Mar. 30, 2023
Percentage Of Note Payable			12.00%
Financing Cost			$ 5,000
Discount Totalling			9,000
Monthly Payment			10,453
Accrued interest			$ 6,805
Accrued interest percentage			12.00%
Individual [Member] | Promissory note [Member]
Proceeds from issuance of debt					$ 25,000
Promissory note issued					50,000
Discount on issuance of promissory note					$ 25,000
Debt due date					February 20, 2020
Noteholder 10 [Member]
Payment of noteholder											$ 25,000	$ 115,000
Monthly payment						$ 7,500	$ 6,250	$ 5,000
Notes Payable Balance									60,000
Convertible debt, Amendment agreement [Member] | Noteholder 8 [Member]
Interest expenses related to Notes Payable									$ 5,833

XML

NONCONTROLLING INTEREST (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2018	Sep. 30, 2023	Mar. 31, 2023
Investments		$ 101,470	$ 101,470
Noncontrolling interest		$ 24,437	$ 24,437
Spring Hill Water Company [Member]
Ownership percentage reduction description	Should we fail to provide this additional capital within the next 2 years, our ownership percentage in Spring Hill will be reduced from 49% to 20%
Ownership percentage	49.00%
Voting membership units, percentage	75.00%
Lease agreement description	Spring Hill will have the use of 2 acres of land and no less than 5 acre-feet of water for an initial term of 25 years and at a lease rate of $1 per year
Capital contribution	$ 100,000
Losses,expenditures, and deductions Percentage	100.00%
Noncontrolling interest percentage	25.00%
Net losses percentage	0.00%
Doore, LLC [Member]
Ownership percentage	51.00%
Bottling Facility And Equipment [Member]
Maximun amount for commitment to additional capital	$ 530,000
Commitment to additional capital term period	2 years

XML

EARNINGS PER SHARE (Details) - shares	6 Months Ended	12 Months Ended
	Sep. 30, 2023	Mar. 31, 2023
Total number of Stock And Debt	26,847,933	25,000,000
Convertible Debt [Member]
Potentially dilutive securities	1,847,933	25,720,373
Preferred Stocks [Member]
Potentially dilutive securities	25,000,000	720,373

XML

STOCKHOLDERS EQUITY (Details Narrative)	12 Months Ended
	Dec. 31, 2022
STOCKHOLDERS EQUITY
Description of common stock	approved a reverse split of the Company’s common stock in the amount of 250 for 1. The reverse split was to be effective during January 2023

XML

COMMITMENTS AND CONTINGENCIES (Details) - USD ($)	6 Months Ended
	Sep. 30, 2023	Mar. 31, 2023
Years Ending March 31,
2024	$ 13,358
2025	25,025
Total remaining lease payments	38,383
Less: imputed interest	(7,710)
Present Value of remaining lease payments	30,673
Current	23,106	$ 23,388
Non current	$ 7,567	$ 19,100
Remaining lease term (years)	1 year 5 months 1 day
Discount rate	5.00%

XML

COMMITMENTS AND CONTINGENCIES (Details Narrative)	Mar. 17, 2021 USD ($)
COMMITMENTS AND CONTINGENCIES
Right of use asset	$ 93,000

XML

SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member]	1 Months Ended
	Oct. 16, 2023 USD ($)
Proceeds from convertible notes	$ 45,000
Description of conversion	is convertible into shares of common stock after 180 days at 61% of the lowest trading price
Maturity date	July 30, 2024